Engineering armoured in vivo CAR T cells through targeted delivery and transient mRNA gating
Hu, K.; Srivastava, S.; Ma, B.; Yang, Y.; Wang, H.; Mangolini, M.; Hayre, J.; Souster, E.; Karattil, R.; Ramon, A.; Greenig, M.; Sormanni, P.; Cordoba, S.; Onuoha, S.
Show abstract
In vivo generation of chimeric antigen receptor (CAR) T cells offers an off-the-shelf, scalable alternative to ex-vivo therapies, but is constrained by inefficiency, toxicity and durability. We report the first armoured in-vivo CAR T platform with tunable, transient activity, that enhances safety and efficacy. Our platform utilises CD8 targeted lipid nanoparticles (LNP) to transiently deliver CAR and armouring membrane-bound IL12 mRNAs. Payloads utilize a T-cell-restricted (T-trex) strategy to constrain CAR and IL-12 expression to T cells, enabling potent antigen-dependent activity with spatio-temporal control. Selective targeting of T-cells with a T-trex CAR showed enhanced expression. The addition of T-trex IL12 mRNA provides a tunable, localised amplification of CAR function, enhancing antigen-dependent cytotoxicity and cytokine production with robust tumour control. These findings establish a novel dose-efficient armoured in-vivo CAR T approach and general framework for programmable immune cell engineering.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Dextran-based T-cell expansion nanoparticles for manufacturing CAR T cells with augmented efficacy 97%
- Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting 95%
- Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine 95%
Similar papers in this journal
- Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates 95%
- Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapy 95%
- A functional screening platform for engineering chimeric antigen receptors with reduced on-target, off-tumour activation 95%
Similar papers in this journal
- CD40 agonistic-monovalent streptavidin fusion antibody for targeted neoantigen peptide delivery and potent cancer vaccination 95%
- Advanced Peptide Nanoparticles Enable Robust and Efficient delivery of gene editors across cell types 94%
- TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccination 94%
Similar papers in this journal
- Enabling non-viral DNA delivery using lipid nanoparticles co-loaded with endogenous anti-inflammatory lipids 95%
- Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 RNP 95%
- Multiplexed inhibition of immunosuppressive genes with Cas13d for on-demand combinatorial cancer immunotherapy 94%
Similar papers in this journal
- Immunofilaments Provide a Nanoscale Platform for In Vivo T Cell Expansion and Cancer Immunotherapy 97%
- Heterologous Prime-Boost with Immunologically Orthogonal Protein Nanoparticles for Peptide Immunofocusing 96%
- SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity Through B Cell Antigen Presentation 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.